We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Aratana Therapeutics Acquires Okapi Sciences NV

News   Jan 07, 2014

 
Aratana Therapeutics Acquires Okapi Sciences NV
 
 
Advertisement
 

RELATED ARTICLES

Significant Public Messaging Required Before COVID-19 Vaccines Are Made Available, Study Says

News

A new BYU study indicates some significant public messaging should be communicated before any COVID-19 vaccines are made available in the US. And with vaccines potentially being approved by the end of the year or early next year, the clock is ticking.

READ MORE

Novel Therapeutic Vaccine Against Leukemia Developed

News

Researchers from the Institute of Process Engineering (IPE) of Chinese Academy of Sciences and Zhujiang Hospital of Southern Medical University have developed a new type of precise therapeutic vaccine against leukemia. It utilizes self-healing polylactic acid microcapsules for co-encapsulating a new epitope peptide and PD-1 antibody.

READ MORE

Johnson & Johnson Temporarily Pauses COVID-19 Vaccine Clinical Trials

News

Pharmaceutical company Johnson & Johnson has paused dosing in all of its COVID-19 vaccine candidate clinical trials due to an "unexplained" illness.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE